Again, I know that no one is listening to me.
But someone must be really kicking the tires. To see about 6,000 shares trade at over 43.70 (at least that is how I read the chart) must mean that something is up.
Wockhardt was the downfall of this company. I say "downfall" because hitk was doing great guns with flonase, and was all set to do over $100 million in sales until wockhardt's Illinois facility of its U.S. subsidiary received fda approval for the generic flonase in January, 2012. Although someone was eventually going to enter the market, and flonase remained a nice product, I was hoping that hitk was going to get another 6 - 9 months with only two other competitors.
Wockhardt has hit a rough spot. It has seen the US put three of its overseas facilities on a no ship US basis. I would normally say that this would not affect the Illinois facility, but one report said that the Wockhardt's "American operations may grind to a halt" - I think that you must discount such a statement because the Illinois facility doesn't seem to be dependent on the India facilities.
One could argue that future Wockhardt anda's are at risk, and that may mean something.
All I would say is this - if wockhardt's flonaise product is stopped, you will see $20 plus prices, and a jump in unit sales. If I was looking at hitk in the past, and was turned off by the flonase competition, I would be taking a real close look again. Maybe that is why we have seen some price action.
hitk has been acting a little strange. It price was above 43.50, the akorn purchase price, for a good part of the day.
Does anyone know if anyone is kicking hitk's tires?? That is the only reason that it would be above the purchase price.
Now we are trading above the purchase price. Maybe someone is really kicking the tires. We can only hope. (and I apologize for using dcdc - it comes up once in awhile and I don't correct it)
Of course, no one is listening to me.
The excitement may have been the anticipation of an SEC filing of a modification, and the settlement of the SEC actions.
The settlement was par for the course (at least in my opinion). They are giving disclosures on certain issues. I don't see any money, other than to the attorneys on this matter.
The only thing I see was that there was, apparently, another bidder in the process last summer (this may have been in the prior SEC filing, but I didn't really look at that). But the lack of any thing since probably means that they weren't as interested.
Seems to be too strong for this stock - trading too close to its purchase price - why?
Is there going to be a dividend (I doubt it because I would suggest that the takeover agreement forbids any dividend). Is there another buyer - I doubt that because it seems a little too late. Is there some litigation going on that is going to produce something - I doubt that because only the lawyers make anything on these cases.
But to trade at $43.48, with a buyout price of 43.50, seems a little strange at this point.
A little excitement this morning. Another company with a similar name to hitk had some products seized by the fda. hitk dropped a point, but has recovered given the clarification that it was not hitk that the fda seized against.
Maybe I should just sell my stock and move on
I thought it was just fine. My son, the expert in this area, thought it was "phenomenal". It was a little longer that it could have been, could have used a little more "snappy" dialogue (although it probably had more than usual), and a little more female influence than usual.
And I believe Disney and Marvel know exactly what they are doing. There will be a sequel, albeit for at least three years (think of the anticipation). And, if this was a "video game", Disney could certainly use some help in that area as that is the one sector that is pulling it down.
They can't take Mattel's brands away from it - Marvel, Star Wars, is up to the highest bidder every few years. Fortunately, for Hasbro, they might have gotten Star Wars on the cheap because they did not expect the Disney purchase.
I am a hitk shareholder. I believe that generics is a growth area. Having my hitk share bought out, I am looking for other generic companies to invest in, not too large (like testa). your company comes to mind.
I am concerned about the earnings and sales. Ironically, hitk, which is a smaller cap company, has lower profit and slightly higher sales. Hitk will nearly double sales and maybe profits (you have to take out the carrying costs of the purchase). Is this price really justified? I know you have a number of applications in the pipeline, but I have my concerns.
The star wars license to hasbro is tied up until 2020. Marvel may be until 2017 (I'm not quite sure of the year for Marvel, but pretty certain on star wars).
We seem to be approaching 45, which is where we should be. But hasbro is up more today.
The rights to the Fantastic Four were licensed by Marvel before Disney purchased Marvel. Disney may get royalties from the movies to some extent, but it does not make the movies for the fantastic four.
I'll continue to talk to myself.
We have seen a nice rebound in the past three days. I think it may be sinking in. Hasbro has more "zip" - it has a few movie tie-ins that will benefit it in the next few years.
But Mattel has better brands - barbie, hot wheels, American Girl, Monster High, Thomas the Tank Engine. It needs to get to the boys better. And it would be nice if it could lache onto something with a technological background.
But it is solid. At least in my opinion. I think we should see 45 in a couple of weeks.
hitk seems to be trading at a high premium - to get only 24 cents in about 3 months seems a little too little. Is anything up? Is there a counter offer? Something with one of these great law firms coming up? A dividend at the year end.
I doubt that it is anything along these lines. But it would be nice.
I'm going to complain. This is a real nice stock right now. It should be over 45, if not approaching 50. It had a bad quarter (maybe), and has recovered nicely.
I shouldn't complain, I guess. I should just buy some more of it.
Very nice earnings and sales. Increased sales of Barbie, Monster Dolls (so there was little cannibalization), and American Girl (something to really grow over the years).
Its been a tough couple of months, but we may see 45+, maybe 50, over the next few weeks. Unless, of course, there is some real breakdown in the economy.
It has been a little frustrating. It started with the last earnings report - not horrible, but a disappointment in some eyes. Maybe the timing of the Easter, and a little weakness in Barbie sales. I think the Barbie sales weakness was offset by their Monster dolls sales, which ate into the Barbie sales. I also think think there were too much expectations. But that lead into concerns going into the holiday season, no real good tie ins to movies, and the weakness in the economy because of DC politics, which adds a little panic. Add to it that their target market is shrinking in age as the technology games (videos, etc) take the older children away as targets. Walmart complaining about inventory didn't help (even though I don't know if it extends to toys) Then Goldman Sachs came out with a downgrade.
Some suggest that Mattel is well poised to take advantage of sales overseas, better than its rivals. The changing age landscape leads me to be concerned, and I can't believe that they are just letting this segment go away, but are slowly plotting to find the right niche (video games are down - maybe the strength in their toys will make a comeback?) - even Disney had to break down and find some way to capture the boys back (boys, unlike girls, aren't thrilled with princesses) - they bought Marvel.
I think their core base of toys give them a continued base for sales overseas, and some steadiness here. American Girls hasn't run its course, here or overseas. Eventually, they will find a way to extend into older children. And don't overlook their buyback of stock - this makes share comparisons look very nice.
The next quarter is a big quarter as they ramp up for Christmas.